Beta Bionics, Inc. — Director's Dealing 2025

Mar 28, 2025

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Beta Bionics, Inc. (BBNX)
CIK: 0001674632
Period of Report: 2025-03-26

Reporting Person: MICHEL GERARD J (N/A)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2025-03-26	Common Stock	A	12547	—	Acquired	12547	Direct

Footnotes

F1: Represents restricted stock unit award granted under the Issuer's 2025 Equity Incentive Plan.